Goreisan (Japanese Kampo) and Intravenous Rehydration in Pediatric Acute Gastroenteritis: Instrumental Variable Analysis
Traditional & Kampo Medicine · 2026-04 · 13 (1)
DOI: 10.1002/tkm2.70053 ↗Kurz gefasst
Fachartikel in der Zeitschrift Traditional & Kampo Medicine, online erschienen am 21.04.2026. Verfasst von Wakana Maki und 2 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health, Labour and Welfare.
Abstract (Originalsprache)
Aim
Goreisan, a Japanese traditional medicine formula (Kampo formula), may be used to manage diarrhea and vomiting in children with acute gastroenteritis (AGE). However, its effectiveness remains unclear. This study aimed to examine the association between Goreisan prescription and subsequent intravenous rehydration in pediatric patients with AGE.
Methods
This retrospective cohort study used data from the JMDC claims database in Japan between 2005 and 2024. Children aged 3 months to under 16 years were enrolled. We excluded patients who had undergone any abdominal surgical procedure within 7 days; those who received intravenous rehydration or were hospitalized during the initial visit; and those diagnosed with peritonitis, appendicitis, or intussusception. To address unmeasured confounding such as disease severity, we used the facility‐level proportion of receipt of Goreisan by children with AGE as the instrumental variable to assess the association between Goreisan prescription at the initial visit and intravenous rehydration within 7 days for AGE.
Results
Overall, 136,267 (4.3%) of 3,179,104 eligible patients (mean age: 61.2 ± 44.6 months) received Goreisan. Instrumental variable analysis found no statistically significant association between Goreisan prescription and intravenous rehydration within 7 days (risk ratio 1.04, 95% CI: 0.83–1.30).
Conclusions
In this large population‐based study, Goreisan prescription for pediatric AGE did not demonstrate a reduced risk of intravenous rehydration within 7 days. These findings provide real‐world evidence on Goreisan prescription, highlighting the need for prospective studies incorporating disease severity and Kampo pattern diagnoses to clarify the role of Goreisan in pediatric AGE management.
Förderung
- Ministry of Health, Labour and Welfare
Zitieren
APA
Maki, W., Aso, S., & Yasunaga, H. (2026). Goreisan (Japanese Kampo) and Intravenous Rehydration in Pediatric Acute Gastroenteritis: Instrumental Variable Analysis. Traditional & Kampo Medicine, 13(1). https://doi.org/10.1002/tkm2.70053
Vancouver
Maki W, Aso S, Yasunaga H. Goreisan (Japanese Kampo) and Intravenous Rehydration in Pediatric Acute Gastroenteritis: Instrumental Variable Analysis. Traditional & Kampo Medicine. 2026;13(1). doi:10.1002/tkm2.70053
BibTeX
@article{Maki2026,
author = {Maki, Wakana and Aso, Shotaro and Yasunaga, Hideo},
title = {Goreisan (Japanese Kampo) and Intravenous Rehydration in Pediatric Acute Gastroenteritis: Instrumental Variable Analysis},
journal = {Traditional & Kampo Medicine},
year = {2026},
volume = {13},
number = {1},
doi = {10.1002/tkm2.70053}
}
EUVIMED